Fanny Hedin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fanny Hedin has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Maria Konstantinou
National Cytometry Platform, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg
3 shared publicationsAljosa Celebic
Translational Medicine Operations Hub, Competence Centre for Methodology and Statistics, Luxembourg Institute of Health, Strassen, Luxembourg
2 shared publicationsAntonio Cosma
National Cytometry Platform, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg
2 shared publications- Antonio Cosma
National Cytometry Platform, Translational Medicine Operations Hub, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg
2 shared publications - Cara L. Carty
Adaptive Biotechnologies, Seattle, Washington, USA
2 shared publications Chantal J. Snoeck
Department of Infection and Immunity, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg
2 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in Mediators of Inflammation
- Vol. 2025 (1)
Immunophenotyping of Patients With Rheumatoid Arthritis Reveals Difference in CD27 + IgD + Unswitched Memory B Cell Profiles
Objectives: Over the past decades, the prevalence of noncommunicable diseases has surged significantly, including the systemic autoimmune disorder rheumatoid arthritis (RA). Despite extensive research and advancement of RA therapy, effective prevention strategies or cures remain elusive, and the mechanisms underlying RA pathogenesis unclear. It is crucial to gain deeper insights into RA pathophysiology. The objective of this study is to provide a comprehensive immunophenotyping of patients with RA. Methods: We generated and analyzed deep immunophenotyping data from 52 patients with RA and 47 healthy controls (HCs). Whole blood samples were stained with extracellular markers, and intracellular antibodies and analyzed for 32 different cell markers using mass cytometry by time of flight. The acquired data was analyzed by both manual and automatic unsupervised tools and subsequently complemented with anthropometric data and clinical‐laboratory parameters. Results: We observed a significant disparity in immune cell profiles between patients with RA and HC, notably a reduced frequency of CD27 + IgD + unswitched memory B ( m B) cells in patients with RA ( p ‐value < 0.01), with the disease RA being the primary and only significant factor explaining up to 17.9% of the variance of these cells. Conclusion: Our results reveal, for the first time, that a reduced frequency of unswitched m B cells in patients with RA is the only significant abnormality distinguishing patients with RA from HC in a complex immunophenotyping panel of 72 different cell populations. This provides important information to further individualize various interventions and possibly help to design novel therapeutic interventions.
- 1 January 2025
- Published by Wiley in Mediators of Inflammation
- Vol. 2025 (1)
Open AccessImmunophenotyping of Patients With Rheumatoid Arthritis Reveals Difference in CD27 + IgD + Unswitched Memory B Cell Profiles
Objectives: Over the past decades, the prevalence of noncommunicable diseases has surged significantly, including the systemic autoimmune disorder rheumatoid arthritis (RA). Despite extensive research and advancement of RA therapy, effective prevention strategies or cures remain elusive, and the mechanisms underlying RA pathogenesis unclear. It is crucial to gain deeper insights into RA pathophysiology. The objective of this study is to provide a comprehensive immunophenotyping of patients with RA. Methods: We generated and analyzed deep immunophenotyping data from 52 patients with RA and 47 healthy controls (HCs). Whole blood samples were stained with extracellular markers, and intracellular antibodies and analyzed for 32 different cell markers using mass cytometry by time of flight. The acquired data was analyzed by both manual and automatic unsupervised tools and subsequently complemented with anthropometric data and clinical‐laboratory parameters. Results: We observed a significant disparity in immune cell profiles between patients with RA and HC, notably a reduced frequency of CD27 + IgD + unswitched memory B ( m B) cells in patients with RA ( p ‐value < 0.01), with the disease RA being the primary and only significant factor explaining up to 17.9% of the variance of these cells. Conclusion: Our results reveal, for the first time, that a reduced frequency of unswitched m B cells in patients with RA is the only significant abnormality distinguishing patients with RA from HC in a complex immunophenotyping panel of 72 different cell populations. This provides important information to further individualize various interventions and possibly help to design novel therapeutic interventions.
- Open Access
- 29 March 2022
- Published by Elsevier in Cell Reports Medicine
- Vol. 3 (4) , 100600
Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients
- 29 March 2022
- Published by Elsevier in Cell Reports Medicine
- Vol. 3 (4) , 100600
Open AccessCombinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients
- 6 May 2021
- Published by Wiley in Cytometry Part A
- Vol. 99 (9) , 930-938
Data integration and visualization techniques for post‐cytometric analysis of complex datasets
The increasing number of measurable markers and the need to integrate flow cytometry datasets with data generated by other high throughput technologies, require the use of innovative tools, easy enough to be used by people with diverse levels of informatics skills. Flow cytometry analysis software has principally been designed for single sample analysis and it does not cover all the successive analysis steps such as integration with metadata and complex visualization. Here, we illustrated the use of data integration and visualization tools generally used in the business sector to analyze datasets generated by mass and flow cytometry. We selected a study that used mass cytometry to characterize immune cells in lung adenocarcinoma and a second study that used flow cytometry to characterize the expression signature of CD markers on human immune cells. These two examples showed the effectiveness of these tools in the analysis of cytometry data and the possibility to expand their use in any field of biology.
- 6 May 2021
- Published by Wiley in Cytometry Part A
- Vol. 99 (9) , 930-938
Data integration and visualization techniques for post‐cytometric analysis of complex datasets
The increasing number of measurable markers and the need to integrate flow cytometry datasets with data generated by other high throughput technologies, require the use of innovative tools, easy enough to be used by people with diverse levels of informatics skills. Flow cytometry analysis software has principally been designed for single sample analysis and it does not cover all the successive analysis steps such as integration with metadata and complex visualization. Here, we illustrated the use of data integration and visualization tools generally used in the business sector to analyze datasets generated by mass and flow cytometry. We selected a study that used mass cytometry to characterize immune cells in lung adenocarcinoma and a second study that used flow cytometry to characterize the expression signature of CD markers on human immune cells. These two examples showed the effectiveness of these tools in the analysis of cytometry data and the possibility to expand their use in any field of biology.
- Open Access
- 1 January 2021
- Published by Elsevier in SSRN Electronic Journal
Systems and Longitudinal Analysis Reveals Early-Stage and Highly Coordinated Immune Responses in Mild COVID-19 Patients
While immunopathology has been widely studied in severe COVID-19 patients, immunoprotective factors in non-hospitalized patients have remained largely elusive. We systematically analyzed 484 peripheral immune cell signatures, various serological parameters and TCR repertoire in a longitudinal cohort of 63 mild and 15 hospitalized patients versus 14 asymptomatic and 26 control individuals. Within three days following PCR diagnosis, we observed coordinated responses of CD4 and CD8 T cells, various antigen presenting cells and antibody-secreting cells in mild, but not hospitalized COVID-19 patients. This early-stage SARS-CoV-2-specific response was predominantly characterized by substantially expanded clonotypes of CD4 and less of CD8 T cells. The early-stage responses of T cells and dendritic cells were highly predictive for later seroconversion and protective antibody levels after three weeks in mild non-hospitalized, but not in hospitalized patients. Our systemic analysis reveals the first full picture and early-stage trajectory of highly-coordinated immune responses in mild COVID-19 patients. Funding: The Predi-COVID study is supported by the Luxembourg National Research Fund (FNR) (Predi-COVID, 14716273) and the André Losch Fondation. We also highly appreciate the expert support of the IBBL processing and biorepository teams. F.Q.H. was partially supported by FNR CORE programme grant (CORE/14/BM/8231540/GeDES), FNR AFR- RIKEN bilateral programme (TregBAR, 11228353, F.Q.H. and M.O.) and PRIDE programme grants (PRIDE/11012546/NEXTIMMUNE and PRIDE/10907093/CRITICS). C.H. was partially supported by the FNR fast-track call COVID-19/2020-1/14703957/COV-Immun. Declaration of Interests: The authors declare that they have no conflict of interest. Ethics Approval Statement: All collections were performed with approval from relevant ethic organizations. Informed consent was obtained from each participant prior to collection. The blood sampling was performed by nurses from Clinical and Epidemiological Investigation Centre (CIEC) of LIH.
- 1 January 2021
- Published by Elsevier in SSRN Electronic Journal
Open AccessSystems and Longitudinal Analysis Reveals Early-Stage and Highly Coordinated Immune Responses in Mild COVID-19 Patients
While immunopathology has been widely studied in severe COVID-19 patients, immunoprotective factors in non-hospitalized patients have remained largely elusive. We systematically analyzed 484 peripheral immune cell signatures, various serological parameters and TCR repertoire in a longitudinal cohort of 63 mild and 15 hospitalized patients versus 14 asymptomatic and 26 control individuals. Within three days following PCR diagnosis, we observed coordinated responses of CD4 and CD8 T cells, various antigen presenting cells and antibody-secreting cells in mild, but not hospitalized COVID-19 patients. This early-stage SARS-CoV-2-specific response was predominantly characterized by substantially expanded clonotypes of CD4 and less of CD8 T cells. The early-stage responses of T cells and dendritic cells were highly predictive for later seroconversion and protective antibody levels after three weeks in mild non-hospitalized, but not in hospitalized patients. Our systemic analysis reveals the first full picture and early-stage trajectory of highly-coordinated immune responses in mild COVID-19 patients. Funding: The Predi-COVID study is supported by the Luxembourg National Research Fund (FNR) (Predi-COVID, 14716273) and the André Losch Fondation. We also highly appreciate the expert support of the IBBL processing and biorepository teams. F.Q.H. was partially supported by FNR CORE programme grant (CORE/14/BM/8231540/GeDES), FNR AFR- RIKEN bilateral programme (TregBAR, 11228353, F.Q.H. and M.O.) and PRIDE programme grants (PRIDE/11012546/NEXTIMMUNE and PRIDE/10907093/CRITICS). C.H. was partially supported by the FNR fast-track call COVID-19/2020-1/14703957/COV-Immun. Declaration of Interests: The authors declare that they have no conflict of interest. Ethics Approval Statement: All collections were performed with approval from relevant ethic organizations. Informed consent was obtained from each participant prior to collection. The blood sampling was performed by nurses from Clinical and Epidemiological Investigation Centre (CIEC) of LIH.